<span item_type="fundamental" item_id="4a01f5f15b47f49c1763f9f9a328d5c5" counter_id="ST/US/BRKRP" env="prod"></span><span item_type="announcement" item_id="578673311506698369" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 860.5 M.</p><p>EPS: As of FY2025 Q3, the actual value is USD -0.41.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -31.8 M.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Bruker Scientific Instruments (BSI)</strong>: Q3 2025 revenues were $787.9 million, a decrease of 1.5% year-over-year, with organic revenue decreasing by 5.4%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1109354/000119312525261638/brkr-ex99_1.htm"></span></li><li><strong>Bruker Energy &amp; Supercon Technologies (BEST)</strong>: Q3 2025 revenues were $73.8 million, an increase of 7.4% year-over-year, with organic revenue, net of intercompany eliminations, increasing by 6.9%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1109354/000119312525261638/brkr-ex99_1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Operating Loss</strong>: Q3 2025 GAAP operating loss was - $51.8 million, compared to GAAP operating income of $68.1 million in Q3 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1109354/000119312525261638/brkr-ex99_1.htm"></span></li><li><strong>Non-GAAP Operating Income</strong>: Q3 2025 non-GAAP operating income was $105.9 million, compared to $129.1 million in Q3 2024, with a non-GAAP operating margin of 12.3%, down from 14.9%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1109354/000119312525261638/brkr-ex99_1.htm"></span></li><li><strong>Net Income</strong>: Q3 2025 GAAP net loss attributable to Bruker Corporation was - $62.4 million, compared to net income of $40.9 million in Q3 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1109354/000119312525261638/brkr-ex99_1.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Operating Cash Flow</strong>: Net cash used in operating activities for Q3 2025 was - $33.2 million, compared to $38.4 million provided in Q3 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1109354/000119312525261638/brkr-ex99_1.htm"></span></li><li><strong>Free Cash Flow</strong>: Q3 2025 free cash flow was - $54.1 million, compared to $5.8 million in Q3 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1109354/000119312525261638/brkr-ex99_1.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Revenue Growth from Acquisitions</strong>: Revenue growth from acquisitions contributed 1.1% to Q3 2025 revenues.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1109354/000119312525261638/brkr-ex99_1.htm"></span></li></ul><h3>Outlook / Guidance</h3><ul><li>Bruker updated its FY 2025 guidance, expecting revenues between $3.41 to $3.44 billion, with reported growth of 1-2% year-over-year and an organic decline of 4-5%. Non-GAAP EPS is expected to be between $1.85 to $1.90, down from $2.41 in FY 2024. The company anticipates significant operating margin expansion and EPS growth in 2026 due to cost-saving initiatives.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1109354/000119312525261638/brkr-ex99_1.htm"></span></li></ul>

Bruker Corp Pref Shares BRKRP 6.375 09/01/2028 | 8-K: FY2025 Q3 Revenue: USD 860.5 M